Prostate Cancer
Disease State Hub
Featured
02/19/2025
Kate Young
Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.
02/19/2025
02/16/2025
Kate Young
Despite strong evidence supporting combination therapy for metastatic hormone-sensitive prostate cancer, androgen-deprivation therapy monotherapy remains common. Do you think you know why? Take the quiz to...
02/16/2025
01/25/2025
Ronald N. Rubin, MD
In a 3-week period, two men present to the office asking for advice regarding prostate cancer screening and evaluations they have undergone in recent weeks.
01/25/2025
Interactive Features
02/16/2025
Kate Young
Despite strong evidence supporting combination therapy for metastatic hormone-sensitive prostate cancer, androgen-deprivation therapy monotherapy remains common. Do you think you know why? Take the quiz to...
02/16/2025
09/15/2024
This pop quiz asks about the treatment options currently recommended for individuals with unfavorable intermediate- or high-risk prostate cancer. Take the quiz to test your knowledge!
09/15/2024
03/30/2024
Disease risk stratification is essential to establishing an appropriate course of treatment in individuals with newly diagnosed prostate cancer. Are you familiar with the latest guidelines by the American...
03/30/2024
01/10/2023
Check out this quick, printable snapshot of the US Preventive Services Task Force's latest prostate cancer screening recommendation statement.
01/10/2023
04/28/2022
One day, Mr G, aged 56 years, came in reporting abnormal urination and back pain. Dr P ordered a prostate-specific antigen (PSA) test, the results of which were 10.96 ng/mL. Based on the results, the...
04/28/2022
Clinical Insights
12/20/2023
In this podcast episode, Stacy Loeb, MD, MSc, PhD (hon), discusses the association between a plant-based diet and prostate cancer risk, how the diet is beneficial in reducing the risk of fatal prostate...
12/20/2023
07/27/2017
Nina Karlin, MD, from the Mayo Clinic in Arizona, discusses her latest research on the interaction between prostate cancer and diabetes.
07/27/2017
05/25/2017
Michael Banks, MD, discusses the benefits of palliative pelvic radiotherapy for treating patients with metastic bladder or prostate cancer.
05/25/2017
